DE LA ROSA, OLGA,LOMBARDO, ELEUTERIO,DALEMANS, WILFRIED
申请号：
CA2906299
公开号：
CA2906299A1
申请日:
2014.03.17
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
The present invention provides a method for determining the clinical prognosis of a human subject to the administration of a pharmaceutical composition comprising of stem cells (preferably mesenchymal stem cells), stromal cells,regulatory T-cells, fibroblasts and combinations thereof.
